Introduction
Geneexpression isthoughttobe centraltothe pathogenesisor progression ofc oronary artery disease(CAD)/atherosclerosis, congestiveh eart failure(CHF)andc ommon congenitalheart disease(CHD). Microarrayanalysisisapowerful techniquefor high-throughput,g lobalt ranscriptonomic profilingofg ene expression. Itholdsgreatp romisef or analysingthe genomic basiso fvarious complexdiseasesandpermits the analysiso f thousandso fg eness imultaneously,b othi ndiseased andnondiseased tissuesand/or cell lines.
Microarrays aremade bydepositingspots ofD NA on a solid support such asacoated glass surface. 1 Aflatglass surface makesitp ossible(i)t oarraym oleculesinaparallelfashion, (ii)t om iniaturisethe procedurea nd(iii)t ou sefl uorescent dyesfor detection andthus avoid radioactivity.Thisdiffers in severalw ays fromconventionalm ethodss uch asfilter-based supportso fc hargednylon andnitrocellulosef or studying mRNAe xpression.
Avariety oftechnologieshasbeenu sed to produce microarrays. Spotted cDNA arrays,produced bydeposition of polymerasec hainr eaction (PCR)p roducts,a ndG eneChip oligonucleotide arrays (Affymetrix; SantaC lara, CA),produced by ins itu synthesiso foligonucleotides,h aveb othb een used successfully.Microarrays cann ow be tailored to focus on aspecific seto fg enes( eg the Cardiochip,withg enesr elated to the cardiovasculars ystemo nly). The advantageso fc DNA arrays arethatt heyaref ocused to aspecificpathwayo r functionalclass ofg enesandwill identifyt he gene(s)o f particularinterest int he tissuestudied.Useofthiss maller chipisl ess expensive, andthe samesamplec anbe used to comparesimilargenesins everals pecies. The limitation of cDNA arrays,h owever,ist hato nly avery limited seto fg enes canbe evaluated.Oligonucleotide arrays havethe advantage ofa llowingoneto monitor every genei nag enomea tt he sametime, rathert hanfocussingon aparticulars ubseto f genes. The disadvantage ist hatt hism ethodi sexpensivea nd the arrays must be madecommercially.Atthistime, only afew organisms( human,mousea ndrat) area vailablef or studies.
Microarrays cans erveto complement othergenetic and genomic tools,i ncludingpositionalcloning 2 andproteomics, 3 to understandthe underlyingb iologicalp athways thatt rigger REVIEW q HENRYSTEWART PUBLICATIONS 1473 -9542. HUMANG ENOMICS .VOL1. NO 5.355-370 AUGUST 2004 or facilitatethe development ofC AD/atherosclerosis,C HF or common CHD.Int hisp aper,the authorsr eviewt he current status ofmicroarrays tudiesinp rofilingg ene expression incardiovasculardisease, withaparticularfocus on humant issuesandc ells.
Expression profilingofC AD CAD iscaused byanaccumulation ofa therosclerotic plaques (atherosclerosis) int he walls ofthe coronary arteries. Atherosclerosisl eadst os ymptoms ofstablea nginai fno clinically apparent plaqueruptureor significant breach ofthe arterial wall occurs,b ut itw ill result inu nstablea ngina, acutemyocardialinfarction (MI)o rs uddencardiac deathonce the arterialw all integrity isl ost andthrombosishaso ccurred.
Inthe USA andmost otherWe stern countries,C AD isthe leadingcauseofmorbidity andmortality.Inthe USA alone, it caused almost onemillion deathsin1999 -twice the number caused bycancerandtent imest he numbercaused byaccidents. 4 Despitesignificant medicaladvances,M Id ueto CAD (andstrokes) isr esponsiblef or mored eathst hanall other causescombined.
Therea retwom aint heoriest hatexplaint he development ofa therosclerosis. First,h igh levels ofc holesterolint he blood injurethe endothelialcells ofacoronary artery,c ausinga n inflammatoryreaction andenablingcholesterolandotherfatty materials to accumulatethere.Secondly,repeated injurytothe wall ofthe artery mayo ccur through various mechanisms involvingthe immunesystemo rbydirectt oxicity withsubstancess uch asn icotineor homocysteine, leadingto the recruitment anda ccumulation ofi nflammatorycells. 5 Inboth cases,therea rec hangest hatcanl eadto the formation of atheromasandplaques. Thesetwot heoriesp robably overlap anda renot mutually exclusive.Todate, severalm icroarray studieshaveb eenr eported to profileg enee xpression inCAD usingh umant issues; onestudyfromt he authors' group focused on the identification ofg enesdifferentially expressed inCAD andnon-CAD coronary arteries, 6 andthe other studieshavec haracterised genee xpression inatherosclerotic plaquesandplaquerupture. [7] [8] [9] [10] Four microarrays tudieshaveso farbeenr eported for the characterisation ofa therosclerosis,oneofwhich focused on restenosisaftercoronary interventions. 9 The current authors used oligonucleotidea rrays to study . 12,000 genesfor their expression inhumancoronary arteries,the targeto rgano f CAD (Ta ble1). 6 Fifty-sixgeness howed differential expression. Int he atherosclerotic coronary artery tissues,the expression of5 5g enesw asincreased, whereaso nly one gene-encodingglutathione-S-transferase( GST),areducing agent -showed downregulated expression. Thiss tudy detected the expression ofg enesp reviously linkedto the generation ofC AD,such as osteopontin expressed ins mooth musclecells, vascularcell adhesion molecule ( VCAM)-1 expressed inendothelialcells and matrixm etalloprotease ( MMP)-9 expressed inm acrophages. Thisl endscredibility to expression profilinga savalid approach for studyingg enee xpression in CAD.
The associations of4 9genesappeared to be novelandh ad not previously beens hownt obe associated withC AD.These included genesencodingretinoic acid responderbinding (RAR)p rotein,b utyrophilin,steroidogenic acuteregulatory protein(STAR),provirusintegration sitefor Moloneymurine leukemia virus-2( PIM-2),signalt ransduceranda ctivator of transcription-91 (STAT-91) andc athepsins Ka ndH .The RAR genei sr egulated byv itaminAsignallingpathways and upregulatest he expression ofthe scavengerr eceptor CD36; 11 butyrophilinhasreceptor functions thatmediatethe transferof lipid; 12 andc athepsins Ka ndHarelysosomalp roteases involved inproteindegradation. 13, 14 STAR isthe rate-limiting stepins teroidogenesisfor the transfero fc holesterolinto the mitochondria. 15 The PIM-2 genei sp resent inm itogenically stimulated hematopoietic cells 16 andi sexpressed widely in the media ofc oronary arteries. 6 The STAT-91 genei sasignal transduceranda ctivator oftranscription inhaematopoietic Ta ble1. Expression profilingofc oronary arteries.
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Humanatherosclerotic plaque 10 Specimens fromr uptured plaqueF ocus on perilipin; consistently upregulated cells. 17 Intercellularadhesion molecule2 ( ICAM-2 )isanother novelgenewhosee xpression isincreased inCAD tissues, anditisexpressed mainly inendothelialcells. 6 GST isthe only genewhosee xpression isr educed inCAD tissues,a ndi t encodesareducinge nzyme. 18 The most significant group of genesidentifiedi nt he present authors' studyw erei nvolved in inflammatoryp rocessesandc onsisted ofg enesexpressed by Ba ndTlymphocytes,a sw ell asm acrophages. Othergenes included fiveg enesinvolved inl ipid transfer,oxidation and metabolism; nineg enesinvolved incell migration,a dhesion andmatrixdegradation; 12 genesinvolved incell necrosis, apoptosisandproliferation; andseveralgenesw ithc urrently unknown functions. AcDNAmicroarraystudywasused to analyse18,376 genes for changesinexpression inw hole-mount humanatherosclerotic plaquesfromt he internalande xternaliliac arteries, aorta, poplitealartery,posterior tibialartery andthe tibiofibulart runkwitha dvanced lesionsascompared withnormal arteries. 7 Similart ot he earliers tudybyArchacki etal., 6 17 genesp reviously connected to atherosclerosis,e gthosec oding for actin , cathepsinS , apoE and P-glycoprotein ,werei dentified, which validatesm icroarrayanalysisasavalid approach for studyingg enee xpression inatherosclerosis. 7 The study identified75newdifferentially expressed genes,4 4ofwhich wereupregulated inadvanced lesions. Differentialexpression of Janus kinase 1(JAK-1 ), vascularendothelialgrowthf actor ( VEGF ) receptor-2 and continuous domain-31 ( CD31)inatherosclerotic plaquesw asconfirmed withreverse-transcription PCR andi mmunocytochemistry.JAK-1isaproteinkinase which mayactivateplatelet-derived growthf actor-b (PDGF) signalling. 7 VEGF receptor-2isareceptor for angiogenic factorVEGF,i tacts asanearly markero fvasculaturei n embryogenesis. 7 CD31 isalso anendothelialcell markerthatis involved inmonocyteandT -cell adhesion to endothelialcells. 7 Thesestudiess upportt he current authors' hypothesist hat endothelialdysfunction isanearly triggeringe vent for the development ofCAD. 2 Thirty-onegenesw eredownregulated inadvanced lesions,whereast he Archacki study 6 identified only oned ownregulated genei ndiseased coronary artery tissues. Alimitation ofthe Hiltunen etal .s tudyist hatv arious arteriesw ereutilised,thus the interpretation ofthe datamay be challenginga sdifferent arteriesm ayhaveuniquec haracteristics. 7 TheH iltunen etal .s tudydid not sharea ny genesin common withthosef oundi nt he current authors' study, discussed above;t hisdiscrepancyingenei dentification betweenstudiesappears to be acommon findinginmicroarray analysiso fa therosclerosis. The potentialexplanationsfor this incongruity maybe thatdifferent arteries( coronary artery versus otheratherosclerotic tissues) wereused indifferent studies,a ndthatt he arteriesu sed werea tdifferent stageso f disease.
The thirdofthe aforementioned microarrayanalysesw asa small-scalestudyw ithc DNA arrays,i nw hich cDNA probes wereh ybridised to nylon arrays containingonly 482genes involved inhaemostasis,i nflammation andc ell adhesion. 8 The studyinvestigated genee xpression inhumancoronary plaquesfromp atients withstableor unstablea ngina.One gene, encodingtissuef actor,showed increased expression in unstablea nginasamples,whereasfiveg enes-i ncluding anticoagulant proteinS , cyclooxygenase-1 ( COX-1 ), interleukin ( IL)-7 andthe chemokines monocytec hemotactic protein ( MCP)-1 and -2 -weree xpressed atl owerl evels inu nstable anginasamples.
Int he fourthmicroarrays tudy,rathert haninvestigating coronary artery disease pers e ,the authorsfocused on restenosis,the most important limitation ofpercutaneous angioplasty procedures( ac ommon surgicalt reatment for patients withc oronary artery disease). 9 Zohlnhofer etal .r etrieved tissuespecimens from1 6p atientsw ithsymptomatic in-stent restenosisu singanovelhelixcutter. Thec ontrol samples included media specimens froms evengastrointestinalarteries andsevencoronary arteriesfromcardiac transplantation. Atlas cDNA arrays (humancancer1 .2,h uman1 .2 cardiovascular, andstress arrays,C lontech)w ereused, andatotalo f2,435 genesw eree xamined.The studyidentifiedseveralgenest hat had previously beenr eported to be expressed ins mooth musclec ells andregulated inn eointimaa ndrestenosis. These included upregulation ofthe thrombospondin-1 ( TSP-1 ), 70-kDa heats hock proteinB , COX-1 genesandd ownregulation of desmin .The studyalso identifiedtwon ewgenest hatare connected to restenosis,FK506 bindingprotein-12 ( FKBP-12) (upregulated)andthe genee ncodingthe mammary-derived growthinhibitor(MDGI)( downregulated). MDGI isapotent tumours uppressor, 19,20 andd ownregulation of MDGI may lead to proliferation andmigration ofsmoothmusclec ells, resultingi nr estenosisaftercoronary interventions. 21 Upregulation of FKBP-12 iss ignificant becausei tisinvolved in controllingtransformingg rowthf actor-b (TGF-b )s ignalling andmayp revent cyclea rrest,leadingto the re-occlusion of coronary arteriesbythe proliferation ofsmoothmusclecells. 19 Thisl atters tudyl ent support to the testingofR apamycin (sirolimus) asanovelp harmacologicalapproach to preventing restenosis,a sitbindst oFKBP-12 andd ownregulatesTGF-b inhibitory activity. 22 Thepotentialu seofR apamycint op revent restenosisisalso supported byt he reportt hatitinhibits smoothmusclec ell (SMC)m igration andproliferation and intimalthickeningafterballoonangioplastyinaporcinemodel ofrestenosis. 23 Inaddition to microarrayanalysis,suppression subtractive hybridisation (SSH)t echnologyw ass uccessfully used to study genee xpression patternsinw hole-mount humans tablea nd ruptured plaques. 10, 24 Thed etails ofthe proceduresinvolved inSSH haveb eendescribed byFaber etal. 10, 24 Compared withmicroarrayanalysis,S SH ism oretime-consumingb ut canl ead to the identification oflow-abundant sequences which maybe missed bym icroarrayt echnology. Perilipinisa phosphoproteinp resent on the surface ofi ntracellularl ipid droplets inadipocytesandsteroidogenic cells, 25,26 Faber etal.
reported thatithad atwofoldd ifference inexpression and wasupregulated inruptured plaques. Asaresult ofthisfinding, itw ashypothesised thatt he overexpression of perilipin increasest riacylglycerols torage byr educingtriacylglycerol hydrolysis. 27,28 Consequently,thisincreasei nl ipid retention mayl eadto plaqued estabilisation andrupture. Perilipin was foundto be consistently expressed ineightr uptured plaques andwascompletely absent ins tableplaques,i dentifyingi tasa uniquemarker. Inaddition,fi bronectinandi mmunoglobulin l chainw ered ownregulated inr uptured plaques.
Ins ummary,the studiesdiscussed aboveh ighlightt he importance ofusingmicroarrays to identifygenesw ith potentialr olesint he generation ofa therosclerosis,i ncluding the evolution ofplaquea ndplaquerupture.Novelgeneshave beenidentifiedwhich mays ervea sfocalp ointso ff uture functionalandpharmacologicalstudiesinanefforttoaltert he process ofa therosclerosis. Furthermore, the combination of microarrayanalysisandpositionalcloningmayp rovide a powerful synergyinthe characterisation ofthe molecularbases ofh umandiseases. First,the genesidentifiedb ym icroarray analysisbecomethe strongc andidateg enesif theyarelocated inapreviously mapped genetic susceptibility locus for the disease.Secondly,the results fromm icroarrayanalysesm ay providei ndependent supportivee vidence for the news ignallingpathwayfor the pathogenesiso fthe diseasei dentifiedb y positionalcloning.Anexcellent exampleisthe authors' recent identification ofthe firstn on-lipid-related disease-causing gene, myocyteenhancerspecific factor-2A ( MEF2A ),for CAD and MI. 2 Usingalarge family with13 patientsw hodisplayed an autosomaldominant inheritance pattern ofC AD andM I, Wa ng etal. successfully identifiedasignificant linkage to CAD/MI on chromosome15q26( LOD score4 .19),the first locus for autosomaldominant CAD andM I( adCAD1 ). The adCAD1 diseaselocus contains 93 known or putativeg enes, andmutationalanalysisestablished oneofthe genesint he region, MEF2A ,a st he generesponsiblef or CAD andM I.A 21 basepairdeletion of MEF2A results inthe deletion ofseven amino acidsint he MEF2Aprotein( D 7aa),a ndc o-segregates withthe diseasei nt he family.Itr educest he transcriptional activation activity of MEF2A byapproximately threefolda nd abolishest he synergistic activation oftranscription by MEF2A incombination withthe Gallus gallus GATA transcription factor-1( GATA-1) through ad ominant-negativemechanism. Usingi mmunostaining, astrongM EF2Aproteins ignalw as detected incultured endothelialcells anda lso withint he endothelium ofc oronary arteries,which isab arrierbetween vessels andb loode lements such ast he platelets andmacrophagest hatarec entralt ot he pathophysiologyo fC AD.The authors' studiess uggest thatanearly stepint he development ofC AD/MI mayinvolved eregulation ofspecific transcriptionalp rogrammesint he endothelium.Defectiveor abnormally developed vascularendothelium will be moresusceptible to inflammation andthe diapedesiso fmonocytes,a nde xpose the subendothelialm atrixt ot he genesiso fa therosclerotic plaqueor thrombosis. Consistent withthe authors' hypothesis, microarrayanalysiso fC AD,a therosclerosisandrestenosis revealed differentialexpression patternso fseveralgenes involved invasculogenesis,a ngiogenesisandvascularremodelling, including extracellulargrowthfactor-1 ( ECGF1 )and MMP-9 inthe studybyArchacki etal ., 6 VEGF receptor 2,JAK-1 and CD31 inthe studybyHiltunen etal ., 7 TSP-1 inthe study byZohlnhofer etal ., 9 and MCP-1 and MCP-2 inthe studyby Randi etal. 8 Itisanticipated thatm icroarrayanalysiswill be increasingly used int he positionalcloningstudiesfor identification ofsusceptibility genesfor complexhumandiseases.
Expression profilingofi schaemic myocardium inanimalm odels
Alimitation ofusingh umant issuesfor microarrayanalysisis thatt herei satremendous amount ofb iologicalv ariability. Astudyofhumantissuesfromt he population usually contains patientsw ithseveralm edicalp roblems,takingseveralm edications andwithprior riskf actorsfor atherosclerosis. Astudy usinga nimalm odels cano vercomethe problemo fb iological variability.Although very limited to date, genee xpression profilingh asbeenp erformed on myocardialt issuesins everal animalm odels thathaveb eenu sed to provide information on the process ofMIinacontrolled setting, enablingthe studyof the genee xpression profileofM I.The precisemechanisms of ischaemic injuryt ot he myocardium secondary to atherosclerosishavenot beenfully elucidated.Withmicroarray technology,h owever,onec anbegint ohaveacomprehensive overviewo fthe genee xpression patternso ccurringi nt he ischaemic heart (Ta ble2).
Rabbitheartst hatw eresubjected to twofive-minute episodesofischaemia (followed byfiveminutesofreperfusion) andthent ofiveh ourso fa dditionalr eperfusion identified 35g enest hatw ered ifferentially expressed. 29 Astrongupregulation of mitogen-activated proteinkinase-activated protein kinase-3 ( MAPKAPK-3 )w asidentified.Itw asinferred that thisgeneh asaprotectivemechanism against cell injury,a sa related gene, MAPKAPK-2 ,isknown to be atheroprotective. 30 Similarly,the sameg roup studied the samemodelo f ischaemia inr atheartss ubjected to a20-minutetransient episode ofi schaemia followed byfour hours ofreperfusion. 31 The purposeofthe studywastodeterminewhetheractivation ofprotectiveg enest akesp lace withinfour hours followinga brief episode ofi schaemia, mimickinga nginapectoris. 31 Ischaemia led to strongupregulation ofmRNA transcripts for heats hock proteins 70,27,105, 86and4 0kDa, VEGF, brain-derived neurotrophic factor,plasminogenactivator inhibitor-1,a ctivatingtranscription factor 3,B -cell translocation gene2andgrowtha rrest andD NA damage inducible4 5 alpha protein. The studydemonstrated thatarapid onset 'genetic reprogramming'o ccursduringabrief episode of ischaemia andc anbe characterised asp rotectivei nn ature.
Stanton etal .studied an invivo ratMI modelbycausinga permanent coronary occlusion. 32 Onamicroarraywith4,000 probes,theyfoundatotalof731 genesdifferentially expressed duringthe 16-week experimentalperiodfromtwo regions of the heart,the leftventricularfree wall andthe interventricular septum.Upregulated genesincluded thoseencodingatrial natriuretic peptide (ANP),sarcoplasmic/endoplasmic reticulum Ca 2 þ -ATPase, collagen,fibronectin,decorin,fibulin,tissue inhibitorofmetalloproteinase-3,fibrillin,laminin,secreted proteinacidic andrich incysteine(SPARC)andosteoblastspecificfactor-2. Thesegeneswereclassified asbelongingto a remodellingpathwayinthe post-MI period.The functional clusteringofthe genelist showed thatthe majority ofthe upregulated geneswereclassified ascytoskeletalandextracellular matrix(ECM)proteins,whiledownregulated geneswere classified ascontractileproteins or fatty acid metabolism-related genes,suggestingaprofoundchange inthe energy-generating processesinthe ischaemic andtheninjured myocardialtissue.
Inthe settingofMI, the angiotensin-convertingenzyme inhibitor,captopril,wasadministered to rats for eightw eeks afterligation oftheirleftcoronary artery. 33 Incontrol animals, therewasanincreased expression ofcollagenIandIII, thrombospondin-4, lysyloxidase, fibronectinandbiglycaneightweeks afterMI.Therewasalso upregulation ofc omponents ofthe complement pathways andlipopolysaccharide bindingproteins andV CAM-1. The downregulation offattyacid metabolising enzymesw asalso documented.Withc aptoprilt reatment, therewasadownregulation ofh ypertrophy-related geness uch as TGF-b 3 and insulin-like growthf actor bindingprotein-6 .These results indicatethatp harmacologicalt reatment int he post-MI periodc anhavea nimpacto ngenee xpression. Many genes werenot affected, however,suggestingthe need for more novelforms oftherapy to alterischaemic damage afteranMI.
Finally,a notherr atm odelemployed to studygene expression int he myocardium,i nduced withthe ligation of the leftanterior descending(LAD)coronary artery,d ocumented genee xpression after2 4hours. 34 Severalgenesdifferentially expressed included genesassociated withc ardiac muscled evelopment such ast he cell cycleregulator p18ink4 andthe structuralp roteins, a -myosinheavy chain ( a -MHC) and fetalm yosinalkalilightchain ( MLC). Expression ofe arly growthresponsef actors Egr-1 and Egr-3 wereupregulated by ischaemia, whereastherewasadownregulation of GST.Other stress responsest oischaemia included aninduction int he expression ofthe apoptosisr egulator Bax ,which maycontributeto cell death.Thisgenelist mayr epresent ab alance betweent he cardioprotectivea ndd egenerativeprocessest hat accompany myocardialischaemia.
Ins ummary,microarrays haveb eenu tilised to understand the consequencesofatherosclerosis,which canabruptly cut off the supply ofb looda ndoxygent ot he myocardium. The microarrayenablesinvestigatorst ol ooka tac omprehensive overviewo fg enetic changesandmays timulatethe development ofpharmacologicalt herapy to altert he processes involved int he consequenceso fM I.Itisinterestingto note thats everalgenesw erei dentifiedb yboththe humanand animalm odels tudies( genesfor 70 kDa heats hock protein, fibronectin,V CAM-1andG ST),suggestingthatm icroarray analysisofanimalmodels isappropriatefor someaspects ofthe characterisation ofh umandiseases.
Expression profilingof endothelialcells
The endothelialcell layero fa nartery ist he firsts trategic location for the initiation ofa therosclerosis. Dysfunction and/or injuryo fe ndothelialcells playanimportant rolei n atherogenesis. 2 The endothelium hasm any functionsfor example, regulation oftone, coagulation and Ta ble2. Expression profilingofi schaemic myocardium inanimalm odels.
Ta rgettissueE xperimentalt reatment
Numberofg enesaffected Itishypothesised thatareaso fthe vasculars ystemw ith turbulent flow aremorelikely to develop atherosclerotic plaquesthanareregions withlaminarbloodflow. 35 Expression profilingwasu sed to examinethe differentialexpression of genesinhumanaortic endothelialcells (HAECs) thatw ere exposed to thesetwoconditions (Ta ble3). 36 Int otal,more than1 30 genesw erei nduced byt urbulent flow ascompared withlaminarflow.Approximately 50p ercent ofthe genes surveyed did haveadetectablee xpression atbaseline, but at twohours3-8 percent ofthe expressed genesw ereupregulated, andb y2 4hours1 4.2 percent -or 50genes-were downregulated.Thestudydemonstrated thatchangesinflow serveasadistinctbiomechanicalstimulus which hasaprofound impactu pon the genee xpression profileofH AEC inv itro.
LDL isw ell established ascontributingto the generation of atherosclerosis. Oxidation ofL DL isak eyevent associated withe ndothelialcell injury,b yl eadingto the expression of endothelialcell receptorst hatbindto inflammatorym olecules. 37 Primary humanu mbilicalv einendothelialcells (HUVECs) weree xposed to oxidised LDL for sixhours. 38 Of the 588 genesevaluated, 78g enesdisplayed ag reatert han twofoldchange inexpression levels:57geneswereupregulated and21 genesw ered ownregulated inr esponseto the oxidised LDL.Oxidised LDL significantly affected the expression of genesencodingtranscription factors,c ell receptors,a dhesion molecules,ECM proteins andenzymesinvolved incholesterol metabolism. Itisinterestingto notethatexpression of retinoic acid receptor-b ( RXR-b )w asu pregulated inboththe turbulent flow andoxidised LDL studies.
Genee xpression hasbeendocumented inendothelialcells infected withpathogens such ashumancytomegalovirus (HCMV)o rCP.Thesepathogens arelinkedto the develop-ment ofvasculardisease, includinga therosclerosis, 39 yett he roleofpathogens inv asculopathieshasbeencontroversial. Expression profilingh asidentifiedmechanisms byw hich CP alters coronary artery endothelialcells. 40 Twenty of268g enes on the arrayw ereupregulated inhumanendothelialcells in responseto CP,suggestingthatCP infection doesnot lead to a generalised responsei ngenee xpression. Genescodingf or cytokines( IL-1 ),c hemokines( MCP-1 and IL-8 )andc ellular growthf actors( heparin-bindinge pidermal-like growthf actor, basic fibroblast growthfactor ( FGF)and PDGF-b chain )w erethe most prominently upregulated inr esponseto the atypicalbacteria. Additionally,i ncreasesint he expression ofg enescodingf or intracellularkinasesandc ell surface receptorsw ithsignal transduction activitiesw ereobserved.Timec oursee xperiments showed thatm RNAlevels wereupregulated within twohoursfollowingi nfection.
Novelgrowthf actorgenesw erea lso identifieda nd included b -FGF , HBGF, PDGF-b and activinA . b -FGF suggested apathwayincommon withe ndothelialcells and SMCs. HBGF isag rowthf actors ynthesised byendothelial cells which canactasapotent mitogenfor the proliferation of SMCs. 41 Similarly,P DGF-b not only hasSMC growthpromotinga ctivity but isalso associated withneointimal proliferation ofS MCs 42 PDGF-b isalso ag rowthf actor accessorym oleculethatm odulatest he activity ofspecific growthf actors. 42 ActivinA, or erythroid differentiation protein,h asbeens hownt om odulatemonocyte/macrophage function,i ncludingi mmunologicalactivation ofmonocytes 43 andthe induction ofMMP-2. 44 CP inducedthe expression of E-selectin , ICAM-2 and VCAM-1 twohoursafterinfection, yetr eturned to basall evels by2 4hourp ost-infection; 45 these genesw erea lso upregulated inr esponseto oxidised LDL. E-selectin and VCAM-1 werea lso upregulated int he endothelialcells exposed to laminarordisturbed flow.Theseresults identifythe responseofendothelialcells to CP bydefiningthe list ofC P-inducibleg enesandprovide newinsights into potentialm echanismso fa therogenesisfromt hesei ntracellular bacteria. Archacki andW ang Review REVIEW Severalo therfactorsdirectly altergenee xpression in endothelialcells. Elevated homocysteinelevels haveb een identifiedasariskfactor for CAD andhavebeenshowntoalter geneexpression inendothelialcells. 46 Usingthe cardiovascular cDNA microarrayapproach, the expression of600 genesin endothelialcells wass creened andasubsetw asidentifieda nd considered to be modulated byhomocysteine. 47 Theyw ere clustered accordingto the function ofthe encoded proteins, such as:e ndothelialm otility,signallinga ndlipid metabolism. Similarly,oligonucleotide arrays wereused to identifygene expression inendothelialcells exposed to nicotine, the major constituent ofc igarettesmoke. 48 Themost significant changes ingenee xpression foundwerethe upregulation ofproteins int he inositol phospholipid pathway,namely phosphatidylinositolp hosphatek inasea ndd iacylglycerolkinase.Changes werea lso detected for transcription factors,c AMP response element bindingproteinandnuclearfactor (NF)-kappa-B.
Ta kabe etal .examined genee xpression inendothelial cells exposed to BO-653,probucol andb ento(h)quinoline (BHQ)-which actasfree-radicals cavenginga ntioxidants. 49 Thesea gents werei nitiallydeveloped asanti-atherosclerotic medications. Among6,416 genes,17 genes-includingthose encodingmitochondrialp roteins andproteins related to oxidativestress responses-wereinduced morethanthreefold byt hesethree drugs. Bycontrast,g eneso fthree subunits of the proteosome( PSMA2 , PSMA3 , PSMA4)w ered ownregulated.The genec odingf or the cytochromeP -4501 A1 isozymepathway,adrugmetabolisingphaseIenzyme, was expressed only byBHQ treatment.
Culturesofcoronary artery endothelium andSMCsderived fromasinglecoronary artery havebeenexposed to IL-1 b and TNF-a ,potent stimulatorso fi nflammation. 50 The most noticeabledifference betweenthe cell typeswasaconsiderable greaterm agnitude andc omplexity ofthe transcriptional responsei nt he endothelialcells. Amongthe 209 regulated genesint he endothelium,99 werenot previously linked directly to atherosclerosisincludingthosethathad been associated withleukocytef unction (eg, IL-7r eceptor, EBI-3 receptor)andothers related to antiviralandantibacterialdefense (eg, oligoadenylatesynthetase , LMP7 , toll-like receptor 4, complement component 3 ). Inaddition,4 3genesl ikely to participate ins ignalt ransduction (eg IL-18receptor, STK2kinase , STAF-50 , ANP receptor, VIP receptor, RAC-3 , IFP-35 )wereexpressed. Thisp rovidesevidence thatamajor effecto fT NF-a and IL-1 b istoalterthe potentialofthe endothelialcell to respond to variouso therexternals timuli.
Insummary,multiplepathways arealtered inendothelial dysfunction. Expression profilinghasdocumented the alterations inexpression ofgroupsofgenesbymany common agents includinglaminarflow,infectious agents such asCP andtoxic agents likehomocysteine, oxidised LDL andnicotine.Alteration ofthe function ofendothelialcells mayserveasthe first strategic location for haltingthe cascade ofevents thatmay followmodification ofgeneexpression inthesecells. Each experimentalprotocol discussed aboveelicited analteration in the expression ofauniqueclusterofgenes. Although most genesw erenot foundto be common amongthe studies,this maybe attributed to the uniqueresponseofthe endothelialcell undert he various conditions. Nevertheless,thismayprovide furtherm edicalstrategiesandtargets for downregulatingthe inflammatoryresponsewhich ultimately leadstoatherosclerosis.
Expression profilingof vascularSMCs
The proliferation,migration andi nvasion ofS MCst hroughout ac oronary artery makeasignificant contribution to atherosclerosis. Lateocclusion ofa utologous saphenous vein grafts (SVGs) isdueto medialandneointimalt hickening secondary to migration andproliferation ofS MCsandthe subsequent formation ofa therosclerotic plaques. Thisp rocess ist he maincauseofrestenosisafterp ercutaneous transluminal coronary angioplasty (PTCA). UnderstandingS MC proliferation mayp rovide insights into the pathogenic mechanisms of CAD,a sw ell asr estenosisafterPTCA.Expression profiling ofSMCshasidentifiedalterations ingeneexpression thatm ay be related to the transition ofquiescent,c ontractileS MCst o proliferativeS MCs.
Humanv ascularSMCsw eree xposed to iloprost,aprostacyclin( PGI 2 )analoguesw hich activatescyclic adenosine 3 0 ,5 0 monophosphatesignalling, which isassociated with maintainingS MCsinaquiescent state(Table4 ). 51 PGI 2 is known to be atheroprotective, asithasbeens hownt oexert many effects such asv asodilation,i nhibition ofplatelet aggregation andmodulation ofc holesterolm etabolism, 52 as well asp reventingS MC proliferation andmigration. 53, 54 Atotalof83genesw eredifferentially expressed sixhours after iloprost exposure.Severalo ftheseg enesaccount for the atheroprotectiveresponseto iloprost. Mitogenactivated protein( MAP)kinasephosphatase-1( MKP-1) hasbeen regarded asac riticalcounteractingf actor for severalt ranscription factors( p38, c-Jun-N-terminalkinase[ JNK], extracellular-signalr elated/regulated kinase[ ERK]),leading to the downregulation ofstimulii nducingthe proliferation of SMCs. 55 The zincfi ngerp rotein,h EZF, isassociated with growtha rrest,a sithasbeens hownt oinhibitDNA synthesis infibroblasts overexpressingthisgene. 56 The gene, Cyr61,was foundto be downregulated byiloprost. Thisgeneplays arole inm ediatingc ell adhesion andmigration anda ugments growthf actor-induced DNA synthesisinfibroblasts. 57 Other criticalgenesinclude: has2 (ofuncertainp hysiologicalconsequence), stanniocalcin (cell protection againstischaemia 58 ), plasminogenactivator inhibitor-1 (its downregulation mayenhance fibrinolytic activity 59 ), MCP-1 (its downregulation mayp revent monocytea ttachment to SMCs 60 ), hemeoxygenase-1 (inhibits SMC proliferation 61 )and COX-1 (promotest he synthesisofprostaglandins andthus isapositiveautoregulatory Expression profilingofc ardiovasculardisease Review REVIEW mechanism for enhancingprostaglandinl evels 62 ). Downregulation of MCP-1 and COX-1 wasidentifiedi natherosclerotic plaquesfromhumanp atientsw ithunstablea ngina. 8 Microarrayanalysisu sing5 58 cardiovascular-associated genesidentified4 7genesdifferentially expressed inp roliferatinga ndnon-proliferatingh umanarterialSMCs. 63 Mosto f the genesint he studyw erea ssociated withthe ECM andc ell motility.Themaingeneg roups identifiedi ncluded matrixorganisingproteins,ECM proteins,cell adhesion proteins,and extracellularcommunication andc ytoskeleton motility proteins. Genesp reviously associated withS MC migration and invasion,such ast hosec odingf or tissuei nhibitoro fmetalloproteinases( TIMP)-2,T IMP-3andM MP-3,werec onfirmed byt he arraydata.Reduced expression ofseveralcytoskeletal proteins,such asv imentin,fi bronectin,c ytokeratins and b 1integrin,wered ownregulated int he invasivephenotype. Furthermore, angio-associated protein, a -E-cateninandb rain ANP receptor wered ownregulated, whereast issuef actor pathwayinhibitor-2( TFPI-2) wass trongly upregulated in invasiveproliferatingSMCs. Consequently,the datadocument the expression profileofe ssentialgenesinSMCsinvolved in the invasiveprocess.
Microarrayanalysisw ith8 ,600 genesidentified . 20-fold increasesinsteady-stateeotaxinmRNA.Moreover,follow-up immunohistochemicals tudiesw ithtissuesamplesfroms even non-diseased and14a therosclerotic arteriesdemonstrated overexpression ofe otaxinp roteinandi ts receptor,C CR3,i n cultured humanaortic SMCst reated withT NF-a (which inducesv ascularinflammation),whereast heirexpression was negligibleinnormalvessels. 64 Thiswasthe firststudytoreport the expression ofe otaxinbyhumanatheroma.Whilethisw as known to be apotent eosinophilchemoattractant anda ctivator, 65, 66 no eosinophils werei dentifiedi nt he targett issue. Similarly,C CR3had previously beeno bserved inm acrophages,mast cells,neutrophils ande ndothelialcells inendobronchialbiopsieso fthe atopic asthmatic lung. 67 The implications ofthe studybyHaley etal .arethatTNF-a may recruitanda ctivatemacrophagesandmast cells through the CCR3r eceptor. 64 Thiss tudym ayl ead to the generation of eithereotaxin-or CCR3-null mice, which mightbe resistant to atherogenesis.
Inaddition to SVGsbeingused for coronary artery bypass grafting, leftandrightinternalm ammary arterieshavea lso beenu sed. 68 The SVGi st he standardconduitfor coronary artery bypass graftingto all areaso fthe heart except the LAD coronary artery.Accelerated atherosclerosiso ccursinv enous conduits such thatduringthe firsty earafterbypass surgery, 15percent ofveingrafts occlude;betweeno nea ndsixy ears, the graftattrition rateis1-2percent peryear; andbetweensix andteny ears,i tis4percent pery ear. 69 Thus,withint he first decade ofbypass surgery,most bypass grafts will be occluded or significantly diseased.Amajor component ofthiso cclusion is the proliferation ofS MCs. Differentially expressed genesin the saphenous veinhaveb eendocumented andc orrelatewith expected genee xpression patterns,i ncludingupregulation of c-Jun andC DK-10. Inaddition,previously unidentified gene expression patternsw ered etected,such ast he upregulation of HSP-70, fibronectin-1 , erbB-3p roto-oncogene and c-myc .
The effectof a -tocopheroltreatment on geneexpression in humanaortic SMCshasbeenstudied becauseitmayaccelerate woundrepairandtissueregeneration duringa therosclerosis. 70 Thismedication isalso oftenrecommended becauseofits antioxidant properties. 71 The expression ofthe connectivetissue growthf actor ( CTGF )genewasinduced by a -tocopherol1 .8fold.Itw ashypothesised thatt hisgenei sinvolved inn ormal repairp rocessesandi sp ermanently overexpressed inp athologicalevents. 70 a -tocopherolm ayeithers timulatethe synthesiso fC TGF or interferewiththe effecto fT NF-a on downregulation ofthisgene.
cDNA arrayt echnologyhasbeenu tilised to unravelt he molecularbasiso fthe antiproliferativee ffecto fb utyrateon vascularSMCs. Butyratei sanaturalfatty acid esterw hich has beenshowntoinhibitSMC proliferation in invitro cell culture systems. 72 Itisderived fromt he microbialm etabolism of dietary fibrei nt he colon,wherei tisp roduced inhigh levels. 73 Itcanfunction asananti-inflammatoryagent by suppressingi ntestinalinflammation, 74 andmayaltergene expression byr eversibly inhibitinghistonedeacetylase, causing the hyperacetylation ofh istonesandtherebyl eadingto selectivechangesingeneexpression. 73 Toassess the involvement of genee xpression inbutyrate-inhibited vascularSMC proliferation,proliferatingvascularSMCswereexposed to butyrate. 75 Ta ble4 . Expression profilingofsmoothmusclec ells (SMCs).
Ta rgettissueE xperimentaldesignNumberofg enesaffected
HumanvascularSMCs 50 Exposureofcells to iloprost 83 Archacki andW ang Review REVIEW Atotalo f111 genesexhibitingmoderate(two-to fivefold)t o strong( . fivefold)differentialexpression werei dentified. Analysisofthesegenesindicatesthatbutyratetreatment mainly alters the expression off our different functionalclasseso f genes,i ncluding4 3genesimplicated incell growtha nd differentiation,13 genesr elated to stress response, 11 genes associated withvascularfunction ande ightgenesn ormally present inn euronalcells. cDNA expression profilesindicate thatbutyrate-inhibited vascularSMC proliferation involvesa combined action ofaproportionallyl arge numbero fb oth positivea ndnegativeregulatorso fg rowth, which ultimately causesgrowtha rrest ofvascularSMCs. 75 For example, the downregulated genesincluded pRb (required for G1toSphase entry), Sphase-specific mus musculus podocan ( PCAN ), G2/M phase-specific cyclinB1 and cdc2 ,and p55cdc.Thedownregulation ofthesec riticalp ositiveregulatorso fc ell cycleprogression indicatest hatbutyratee xertsits antiproliferativee ffectby alteringk eyp ositiveregulatorso fa ll phaseso fc ell cycleprogression. Furthermore, butyratea lso appeared to block SMC proliferation byupregulatingnegativeregulatorsofcell growth or differentiation inducers such as p21waf1 , p14INK4B/ p15INK5B and clusterin .Consequently,the identification of the molecularm echanisms ofb utyrate-inhibited proliferation isimportant,not only to understandthe molecularbasiso f butyrate-induced SMC proliferation,b ut alsobecauseofi ts potentialu sea satherapeutic agent to prevent restenosiso f arteriesinhumans.
Insummary,smoothmusclecell proliferation contributesto the formation ofatherosclerotic lesionsandrestenosisafter angioplasty,andmicroarraystudieshaveidentifiedmultiple genesthatareinvolved inthisprocess.Understandingthe molecularmechanisms involved mayprovide novelinsights into pharmacologicalapproachestopreventingSMC migration.
Expression profilingof inflammatorycells
Inflammatorycells playanimportant rolei nt he development ofC AD.First,monocyterecruitment isak eyevent int he formation ofthe earliest vascularl esion,the fatty streak. Secondly,macrophage uptakeofmodified LDLsv ia scavenger receptorsgivesr iseto foamcells int he atheroma, andthese secreteg rowthf actors,c ytokinesandi nflammatorym ediators thatinfluence the growtha ndd evelopment ofothercell types withint he atherosclerotic lesion,g eneratingplaques. Microarrays havebeenused to profilegeneexpression changesinthe inflammatorycells inr elation to the formation ofa therosclerotic lesions.
Genee xpression ofmacrophageshasbeenanalysed using microarrays containinga pproximately 16,000 human cDNAs(Ta ble5). 76 The humanmonocytic leukaemia cell line (THP-1) wast reated withoxidised LDL.The cells werethen activated byt reatment withlipopolysaccharide (LPS),a nd RNA washarvested atz ero,onea ndsixhoursafterLPS addition. Oxidised LDL treatment affected the expression of 57o f127 genesinm acrophages. Amongthemareg enes thatcode for potent intracellularande xtracellulars ignalling moleculess uch asNF-k B, A20 andnumerous cytokinesand chemokines. Oxidised LDL pretreatment resulted inasignificant change inLPS-induced NF-k Ba ctivation. Someofthe oxidised LDL effects weremediated byt he nuclearr eceptors RXR andperoxisomalp roliferator-activated receptor-g .
Tofurtherdefinethe mechanisms byw hich LDLparticles affectm acrophagesandf oamcells,alarge-scaleg ene expression analysiso fc holesterol-loaded macrophagesw as carried out. 77 Oxidised LDL-treated andtime-matched control untreated cells wereh ybridised to microarrays containing 9,808h umangenes. Two hundred andsixty-eightgenesw ere foundto be differentially expressed atl east twofolda to neor moretimepoints. Thesepatternso fregulation werec lassified into sevenclusters.Shiffman etal. identifiedpatternso fg ene expression ofk nown andnovelm olecularcomponents ofthe cellularr esponsethatarei mplicated int he growth, survival, migratory,i nflammatoryandmatrixr emodellinga ctivity of vesselw all macrophages. 77 The datai ndicatethato xidised LDL loadingofT HP-1cells did not elicitany measurable immediately transcriptionalr esponsef romt he geness tudied untilday4.The novelandmost highly upregulated genes identifiedwere: DSCR1,liveranda ctivation-regulated chemokine Similarly,D NA microarrays wereused to definethe changesingenee xpression profilei nr esponseto copper exposureofh umanm acrophages. 78 Serumcopperhasbeen shownt obe associated withc ardiovasculardisease(a3.5-fold increased riskofacuteMI)but its mechanism ofaction hasnot beenidentified. 79 The results showed thatexpression of91 genesw erea ltered.Copperincreased the expression ofseven cholesterogenic genes( 3-hydroxy-3-methylglutarylcoenzymeA synthase , isopentenylp yrophosphatei somerase , squalenesynthase , squalenee poxidase , methyl sterol oxidase , H105e3m RNA and sterol-C5-desaturase )andthe genee ncodingthe LDL receptor, andd ecreased the expression of CD36 andlipid-binding proteins.Thus,c opperactivatescholesterogenic genesin macrophagesinvolved inLDL uptakea nd de novo cholesterol biosynthesis. Thisl eadst ol ipid accumulation int he inflammatorycells andthus the arterialw all.
Genee xpression wasalso studied inl ymphocytesexposed to arsenic,which isassociated witha nincreased riskf or vasculardisease. 80 Patientsw eree xposed to low,i ntermediateor high levels ofa rsenic asdetermined bym onitoringserum levels. Atotalo f62 geness howed asignificant difference in the intermediateandhigh levels ofbloodarsenic,ascompared withlowl evels. Theseg enesincluded thosee ncoding IL-1 b , IL-6 , chemokineC -C motif ligand2/MCP-1 , chemokineC -X-C motif ligand1/growth-related oncogene-a , chemokineC -X-C motif ligand2/growth-related oncogene-b , CD14a ntigen and MMP-1 .
The effecto fb iomechanicalforceso nm acrophagef unctions inatherosclerosisw asdetermined bym icroarrays with 1,056genes. 81 Mechanicaldeformation at1Hzw asapplied to athintransparent membraneon which the cells werecultured. Thisinduced only three genest om orethan2 .5-foldh igher expression att hree andsixhours: prostatea poptosisr esponse-4 (3.0-folda tt hree hours,6.7-folda ts ixhours), IL-8 (4.3-fold ats ixhours) andthe immediate-earlyr esponse gene, IEX-1 (2.6folda ts ixhours). IL-8 maybe important int he initiation and amplification ofi nflammation anda ngiogenesisinatherosclerosis,b ecausei tischemotactic for vascularSMCs,T lymphocytesandneutrophils. 82 Italso triggers the firm adhesion ofmonocytest ot he vascularendothelium. 83 IEX-1 isanNF-k B-induciblei mmediate-early genewhich inhibits apoptosis. 84 Itm ayalso participatei nt he differentiation of monocytes/macrophages. Protease-activated receptor-4 (PAR-4)isknown to be awidely expressed proteinw hich confers sensitisation to apoptosis-induced insults. 85 Consequently,J ohnstone etal .demonstrated thathumanm onocytic cells respondto mechanicaldeformation withi nduction of immediate-earlyandi nflammatorygenes. Thiss uggests that mechanicals tress inv ivo,such ast hatassociated withh ypertension,mayp layanimportant part inatherogenesisand instability ofc oronary artery plaquest hrough biomechanical effects on vascularm acrophages.
Humanm onocyte-derived macrophagesfromhealthym ale andf emaled onorshaveb eenexposed to androgen( dihydrotestosterone)inaneffortt odetectgender-specific changesin genee xpression, 86 asithasalreadybeenestablished thatt here isag enderdifference int he severity ofd isease, withmen havingmoreseverec oronary artery diseasethanw omen. 87 In macrophagesharvested fromm ales,treatment witha ndrogen resulted int he differentialu pregulation of27 genes,whereas nonewasupregulated infemaleharvested macrophages. Some ofthesegenesdirectly related to the process ofa therosclerosis, includingthe upregulation of acyl coenzymeA :cholesterol acyl transferaseIand lysosomalacid lipase ( LAL) -which playarole int he delivery oflipoproteins to cells, 88 caveolin-2 , CD40 , leukotrieneB 4receptor and cadherin-19 (the lattert hree playa rolei ninducingc ell surface receptorsfor monocytea ttachment 89 ). Functionals tudiest ocomplement the microarray results showed ad irectclinicalcorrelation withL AL, int hat therewasac onsistent increasei nactivity with 125 I-AcLDL exposure. 88 Itcanbe concludedthatandrogenexposurea sit occursn aturally int he maleg enderisdirectly responsiblef or inducingg enesassociated withthe development ofa therosclerosisandmayaccount for genderdifferencesint he incidence ofC AD.
Expression profilingofC HF
CHF isaterm used to describe any condition inw hich the heart isu nableto generatea nadequatepressureto pump bloodthroughout the body. Thiscondition causess ymptoms such ass hortness ofb reath(dyspnoea),f atigue, weakness and swelling(oedema)o fthe legsandsometimesint he abdomen (ascites).Anestimated 4.8million Americans haveCHF, 90 and halfofa ll patientsdiagnosed withC HF will be dead within fiveyears.Each year,thereareanestimated 700,000 newcases int he USA.Increasingprevalence,h ospitalisations andd eaths havemade CHF amajor chronic condition int he USA.It ofteno ccursast he endstageofc ardiac disease, referred to as ischaemic cardiomyopathy( ICM)dueto severeC AD. Expression profilingofh umancardiac tissueshasbeen employed to identifygeneswhoseexpression islinkedto CHF, andthesestudiesaresummarised below.
Oligonucleotide microarrays wereused to profileseven non-failing(NF)ande ightfailing(F)humanheartsw itha diagnosiso fe nd-stage dilated cardiomyopathy( DCM) (Ta ble6). 91 Of 6,606 geneso nt he microarray,103 genesin tenfunctionalgroupsw ered ifferentially expressed betweenF Archacki andW ang Review REVIEW andN Fh earts. InFh earts,Kmeans clusteringrevealed two potentially novelp athways associated withup-regulation of atrialn atriuretic factor and brainn atriuretic peptide andwith increased expression ofE CM proteins.Ad endrogramo r genetic profileofthe twot issuesdistinguished twoFh earts withd istinctaetiologies( familialanda lcoholic cardiomyopathy,respectively). The studydemonstrated thatt herei sa uniquemoleculars ignaturei nFh earts.
Similarly,a'genomic portrait' ofh eart failured erived with microarrays waso btained fromend-stage DCM usingthe CardioChipw ithnon-redundant 10,848-element human cardiovascular-based ESTs. 92 Morethan1 00 transcripts were consistently differentially expressed inDCM . 1.5-fold(versus pooled NF hearts). ANP wasalso foundto be upregulated in DCM (19-foldcompared withNFhearts) aswell asnumerous sarcomeric andc ytoskeletalp roteins (eg cardiac troponin, tropomyosin),stress responseproteins (eg HSP-40,H SP-70) andtranscription/translation regulators( eg CCAATb ox bindingfactor,eIF-1AY). Downregulated geneswereclassified ascell-signallingc hannels andmediators,particularlyt hose involved incalcium pathways ( calcium/calmodulin-dependent kinase , inositol1 ,4,5-trisphosphatereceptor and sarcoplasmic reticulum Ca 2 þ -ATPase [ SERCA]). Severalnovel,cardiacenriched ESTswerealso co-expressed.The studydemonstrated acommon expression pattern amongthe sets ofsampleswith DCM anddocuments agenelist thatmayserveaspossible targets for therapeutic intervention specific to cardiac tissue.
Also usingpatients withe itherDCM or hypertrophic cardiomyopathy( HCM)atend-stage CHF,H wang etal. generated alist ofpredictivemarkers for thesetwo diseases. 93 Similart op revious studies,ANP andS ERCA werefoundto be increased andd ecreased, respectively,and thisw asconsistent inall ofthe tissuess tudied.Othergenes havingthe samee xpression levels inbothD CM andH CM tissuesincluded: copper/zincsuperoxide dismutase , heats hock protein9 0 , elongation factor-2 , calcium-activated neutralprotease , decorin and CD59 .Genesfoundto be differentially expressed betweenDCM andH CM included atrialm yosinalkalilight chain , calsequestrin , lipocortin and lumican ,which wereupregulated, while myc transcriptionalactivity and b -dystrobrevin weredownregulated.Intotal,the studydocumented 192 genes. Asint he previous studiesr eviewed, ANP and SERCA displayed the samee xpression patternsconsistently inboth populations ofsamples.
Ta ble6. Expression profilingofc ongestiveh eart failure(CHF).
Ta rgettissueE xperimentaldesignNumberofg enesaffected
End-stage dilated cardiomyopathy( CM) 91
Failingversus non-failing103
End-stage dilated CM 92 Failingversus non-failing100 InastudybySteenman etal .,the expression profilesoffour specificpathophysiologicalcardiac situations wasanalysed: i)l eftv entricle(LV)fromNF heart;ii)LV fromFh eart affected byDCM;iii)LV fromFh eart affected byICM;and iv) rightv entricle(RV )fromFh eart affected byDCMor ICM. 94 Microarrays representinga pproximately 12,000 humangeneswereutilised.The authorsidentified1,306 genes withasimilarexpression profilei nall four cardiac situations. The upregulation ofe mbryonic myosinalkalilightchain-C1 ( MLC1emb ), calponin and SM22 represented areversalt o developmentalgenee xpression such aso ccursincardiac remodellinga ndC HF.The expression ofsmoothmuscle myosinheavy chainandsmoothmuscle a -actinr epresented a dedifferentiation process.Severalapoptosis-related genesw ere identifiedi nFL Vand/or RV samples,with CDKN1A showingthe most markeda ctivation. Stress-induciblemetallothionein wasalso upregulated;t hisfunctions asanantioxidant andinhibits the production ofa trialnatriuretic factor. 95 Novel genesincluded AF1a ,atransmembraneprotein, 96 and SH3BGR .Relatively fewgenesw ered ifferentially expressed betweenFL VandFRV samples,yett he most marked difference wasfoundi nt he geneprofiling, anactin-binding proteinbeingimplicated inthe control ofactinpolymerisation andc ytoskeletalr eorganisation. 97 Finally,no genesw ere significantly differentially expressed betweenDCM and ICM Fh earts,which indicatest hatall heartsw erec linically infailure.
Inaseparatestudy,oligonucleotidea rrays havei dentified specificg enesexpressed inp atientsw ithC HF,screeningover 7,000 genesint wo NF andtwoFh umanheartsw ithd iagnoseso fe nd-stage ICM andD CM. 98 Genesw erec ategorised into fiveg roups:(a)cytoskeletalandmyofibrillargenes ( myomesin , non-sarcomeric myosinr egulatoryl ightchain-2 [ MLC2 ] and ss-actin ); (b)genesr esponsiblef or the degradation and disassembly ofmyocardialp roteins (alpha-1-antichymotrypsin , ubiquitin and gelsolin ); (c)genesinvolved inm etabolism ( ATPsynthasea lpha-subunit , succinated ehydrogenasefl avoprotein [ SDHF p ] subunit , aldosereductase and translocator ofi nner membrane-17 [ TIM-17] preproteint ranslocase ); (d)genes responsiblef or proteins ynthesis( elongation factor-2 [ EF-2 ], eukaryotic initiation factor-4AII and transcription factor homologue-HBZ17); and(e)genesencodingstress proteins ( a -B-crystallin and m -crystallin ). The studyfocused on the novels triated muscleL IM protein-1( SLIM1 )genea sbeingc onsistently downregulated inCHF.Although the precisef unction of SLIM1 hasn ot beendetermined, itishypothesised that itm ayactasascaffoldf or interaction betweent hinfilaments andthe cytoskeleton, 99 inasimilarw ayt om uscle Lin-11-Isl-1-Mec-3( LIM)p rotein( ML). Myosin-like protein( MLP )knockout mice haveb eens hownt odevelop DCM. 100 All ofthe identifiedg enesm aycontributeto development ofthe heart failurephenotypea ndrepresent compensatorym echanisms to sustaincardiac function in failingh umanhearts.
Similarly,Steenbergen etal. used DNA microarrayprofiling to investigatec hangesint he expression ofg enesinvolved in the apoptosist hato ccursinhumanidiopathic DCM hearts thathaveprogressed to CHF. 101 Theydocumented altered genee xpression consistent withapro-apoptotic shiftint he TNF-a signallingpathway. Specifically,theyfoundd ecreased expression of TNF-a -a nd NF-k B -induced anti-apoptotic geness uch as growtha rrest andD NA damage-inducible ( GADD) 45-b , Flice inhibitoryp rotein ( FLIP)and TNF-induced protein3 ( A20)genes. Theyalso observed asignificant decreasei nt he phosphorylation ofB d-acceleratinga poptosis( BAD)at Ser-112,which isalso consistent witharolef or apoptosisin heart failure.
Oneoption for improvingleftv entricularfunction in CHF ist he useofaleftv entricularassist device (LVAD). The unloadingofthe Fh eart witha nLVAD candecreasec ardiac mass andmyocytesizea ndh ast he potentialt oimprove contractilef unction. Severals tudieshaved ocumented changesingenee xpression broughtaboutbyt he presence of anLVAD.The effecto fc hronic ventricularu nloadingon myocardialgenee xpression wascompared beforea nda fter LVAD supportins evenp atientsw ithi diopathicD CM and end-stage CHF. 102 Onaverage,1,374g enesw erereported as 'increased'and1,629 'decreased'afterLVAD support. Upregulated genesincluded alarge proportion oftranscription factors,g enesr elated to cell growth/apoptosis/DNA repair, cell structureproteins,metabolism andc ell signalling/communication. LVAD support resulted indownregulation of genescodingf or cytokines. Similarly,C hen etal .p erformed transcriptionalp rofilingusingaspotted cDNA microarray with12,814uniquec loneso np aired sampleso fL Vobtained beforea nda fterp lacement ofa nLVAD in1 1p atients. 103 The most significantly upregulated genewast he G-protein-coupled receptor APJ,the specific receptor for apelin. Blaxall etal . also examined genee xpression,performingoligonucleotide arrays withL Vsamplesfroms ixm alepatients which were harvested duringL VADplacement anda tt he timeof explantation. 104 Thesea uthorsdocumented asignificant difference int he correspondingL VAD-mediated regulation of genee xpression andwerea bleto distinguish, inab lind manner,patients withd ifferent CHF aetiologies.
Finally,microarrays wereutilised on paired sampleso f humant issuef romp atients withC HF witha ndwithout an LVAD. 105 Afters everals tatisticalanalyseso fthe data, approximately 85 upregulated geneswereidentified.The focus ofthe studyw aso napelin,which wast he most significantly upregulated genea ndwasl ocalised primarily int he endothelium ofthe coronary arteriesaftert he mechanicalo ffloadingb yt he LVAD.Thisfindingi mpliesanimportant paracrinesignallingpathwayint he Fheart.Thei dentification ofthisgeneled to the measurement ofserumapelinl evels. Theseweref oundto be increased int he serumo fpatients withFheartsandmays ervea sab iologicalm arkerinp atients withC HF.
Archacki andW ang Review REVIEW
Ins ummary,microarrayanalysiso fC HF canr evealt he underlyingmolecularm echanisms regulatingh ypertrophyand proliferation,a sw ell asapoptosiso fc ardiomyocytes. These studiesr evealed the dysregulation ofvarious molecularp athways involved inCHF.
Expression profilingofC HD
Congenitalheart defects account for the largest numberofbirth defects inhumans. 4 Thea pplication ofe xpression profiling inp atientsw ithC HD iss till inits infancy. Todate, only one microarrays tudyhasdocumented genee xpression inCHD.
Microarrayanalysisw ascarried out incardiac samplescollected duringc ardiac surgery,f roms ixn ormals amplesand from55 patient samplesw ithvarious cardiac defects. 106 HumanUnigeneS et-RZPD 2cDNA arrays with12,657 known genesw ereused.The studyidentifiedspecific moleculars ignaturesfor tetralogyo fF allot (TOF),ventricular septaldefects (VSDs) andrightv entricularhypertrophy (RV H),e ach ofwhich hasad istinctgenee xpression profile. TOFa ndR VH weref oundto be associated withg eneso f variousfunctionalclasses,a ndc anbe clearly distinguished by different moleculars ignatures. TheT OF signaturec onsists of many genesinvolved inthe cell cycleandcardiac development (eg upregulation ofswitch nuclearB-siteprotein[ SNIP], A2BP1 and KIAA1437,a ndd ownregulation of STK33, BRDG1 and TEKT2 )andthe upregulation ofribosomal proteins S6 , L37a , S3A , S14 and L13A .The RV Hsignature includesgenesm ainlyinvolved int he stress response, cell proliferation andmetabolism -for example, the upregulation ofADD2. VSDshavebeenassociated withaspecific signature consistingofd ownregulation ofg enesfor ribosomalp roteins S11, L18A, L36,L P0 , L31 and MRPS7 ,a ndd ownregulation ofg enesinvolved incell proliferation,d ifferentiation and apoptosis( eg S-adenosyl-methionined ecarboxylase [ AMD1 ], receptor interactingproteins erine-threoninek inase-3 [ RIPK3 ], Egl-Nineg enef amily [ EGLN1 ], humans iah bindingprotein-1 [ SIAHBP1 ], and Armadillarepeat-proteininv elo-cardiofacials yndrome [ ARVCF ]). Severalion channelgenes,i ncluding SLC26A8, SLC16A5, SLC4A7 , KCNS2 and KCNN3 ,were foundto be differentially expressed inVSD tissues. The study also identifiedh eart chamber-specific expression ofmany genes. The humanheart consists oftwoatria andtwov entricles. The atria havebeenfoundto havehigherexpression of genesfor ECM or actinm odulation,such asclevage stimulatingf actor-3( CST3 )andprocollagenCOOH-terminal proteinasee nhancerp rotein( PCOLCE),translation factor EEF1A andthe DNA helicaseRecQ protein-like-4 ( REQL4) andapotassium channels ubunit KCNIP2 .Geneswithh igher expression int he ventriclesencode proteins for cytoskeleton contraction,metabolism -energyt urnoverandc ell cyclegrowth, andinclude TMP1 , humanfactor H-like protein ( FHL1 ) andthe musclea nkyrinr epeatp rotein ( ANKRD2 ).
Conclusions
The availability ofc DNA andoligonucleotide microarrays withseveralt housandh umangenesm akesitp ossibleto study globalchangesingenee xpression inCAD,C HF andC HD. Thesestudieshavei dentifiednovelgenesandpathways involved inthe generation ofthesediseasesatboththe organ/ tissuelevel( coronary arteries,c ardiac tissues) andc ell level (endothelialcells,vascularSMCs,macrophages). Itisimportant to notethats everals tudieshavec onfirmed the expression ofg enesp reviously linkedwiththesed iseaseprocesses, suggestingthatexpression profilingwithmicroarrays isavalid approach for identifyingg enee xpression alterations associated withd isease.Ye t,many morenovelgeneshavea lso been identifieda ndwill servea savaluableresource for identifying novelpathways involved inthe generation ofdisease.Withthe continued useofthist echnology,a nda naccelerated application to thesed iseases,wewill eventually identifyac ommon group ofgeneswhich will be ableto serveasmarkers for these diseaseprocessesonaglobalscale.Itisimportant,however,to notethatdifferent studieshaveidentifieddifferent sets ofgenes associated withthesed iseases. Thus,the microarrayr esults remaint obe replicated inanindependent seto fsamplesand caution needst obe takenw heninterpretingtheseresults. In addition,amajor limitation ofmicroarrayanalysisist hatitis usuallydifficultt odistinguishwhethert he identifiedd ifferentialgenee xpression patternsarethe causeor the consequence ofthe disease.Follow-up studiesw ithtransgenic overexpression or knockout ofthe geneofi nterest inanimal models areneeded to solvethisissue.Furthermore, microarray analysisisbiased to the genesonthe arrays andcannot be used to evaluatelow-abundant transcripts. Microarrayanalysisalso results infalse-positives; itist hereforec rucialt hatr esults are confirmed usingc onventionalt echnologies,such asq uantitativereal-timeP CR,quantitativereverse-transcription PCR, Northern blot,W estern blot or immunostaininga nalyses. Finally,the expression levelo fmRNA doesn ot necessarily reflectt he expression ofthe protein,a ndthe pathogenic mechanism ofadiseasemayinvolveproteinm odifications such asp hosphorylation andg lycosylation. Undert hesec ircumstances,proteomicswill proveto be apowerful,alternative technology. The firstp roteomicsanalysishasbeenp erformed for CAD bythe authorsofthisp aper,andthe studyidentified the ferritinl ightchainasasignificant markerfor diseased coronary arteries. 3 Itisimportant to point out thatproteomics cananalysef arfewergenest hancanm icroarrays,a st he resolution ofthe common two-dimensionalgels eparation of proteinextracts islimited to only afewthousandproteinspots. Proteomicsalso sharess omec ommon limitationsw ith microarrayanalysis; for example, itcannot be used to evaluate low-abundant proteins/genes. Nevertheless,microarrayanalysiscangeneratenovel hypothesesr elatingto the pathologieso fthesed iseases,a nd furthers tudiesw itha nimalm odels,molecularbiology,c ell Expression profilingofc ardiovasculardisease Review REVIEW biologyandb iochemistry will validatetheseh ypothesesand providenovelinsights into the pathogenesiso fd isease.These studiesw ill eventually generatenoveldiagnostic andtherapeutic markers,a ndi dentifyp otentialdrugtargets which will serveto bringa boutm oree ffectivemanagement ofc ardiovasculardisease. 16 . 
